Trial Profile
A phase I trial of PPP004, a topical cannabiniod based product, for the treatment of general neuropathic pain
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 20 Jun 2018
Price :
$35
*
At a glance
- Drugs PPP-004 (Primary)
- Indications Neuropathic pain
- Focus Adverse reactions
- 20 Jun 2018 According to a Tetra Bio-Pharma Inc. media release, the company will file request to commence this trial in the third quarter of 2018.
- 20 Jun 2018 New trial record